Friday, November 4, 2022
10:25-16:00 Central European Time (CET)
10:25 Welcome Note
Yuval Yaron, Israel
10:30-11:00 Clinical use cases of Prenatal Genome Sequencing
Sponsored symposium- Illumina
10:30-10:45 From prenatal exome sequencing to prenatal genome sequencing: takeaways from >1500 cases
Peter Bauer, Centogene, Germany
10:45-11:00 Clinical application of prenatal WGS with an in silico gene panel for detecting genetic causes to non-immune hydrops fetalis
Eini Westenius, Sweden
11:00-12:30 Session 1: Advances in Prenatal Diagnosis
11:00-11:30 Prenatal ES for the investigation of congenital malformations: the UK experience
Mark Kilby, UK
11:30-12:00 Prenatal exome and genome sequencing in pregnancy
Neeta Vora, USA
12:00-12:30 Genetics of fetal growth restriction
Toni Borrell, Catalunya
12:30-13:30 Developments in Rolling Circle Amplification for Prenatal Screening

Sponsored symposium- Perkin Elmer

Tarja Ahola, Finland
  Screening for main aneuploidies with Rolling Circle Amplification in twin pregnancies
Alexandre Vivanti, France
  Evaluation of a simplified cfDNA screening method for common autosomal trisomies: Issues and updates
Geralyn Lambert-Messerlian, USA
  Prenatal screening performance of the RCA methodology
Glenn E. Palomaki, USA
  Live Q&A Session
Alexandre Vivanti, France; Geralyn Lambert-Messerlian, USA; Glenn E. Palomaki, USA; Olof Karlberg, Sweden
13:30-16:00 Session 2: Non-Invasive Prenatal testing
13:30-14:00 CLIA lab experience with a non-invasive cell-based prenatal genetic test
Art Beaudet, LunaGenetics, USA
14:00-14:30 Cell-based NIPT: a new approach for prenatal testing
Francesca Romana Grati, Menarini Biomarkers, Italy
14:30-15:00 Cell based NIPT – Special focus on screening for cystic fibrosis by detecting the 50 most common variants in the CFTR gene
Line Dahl Jeppesen, ARCEDI, Denmark
15:00-15:30 cfDNA testing: the more the better?
Liona Poon, Hong Kong
15:30-16:00 The NIPT model implemented in England
Pranav P Pandya, UK
Saturday, November 5, 2022
10:30-14:30 Central European Time (CET)
10:30-11:30 A CE-marked IVDD Preimplantation Genetic Analysis Solution of Aneuploidies in Embryos
Sponsored symposium- Thermo Fisher Scientific
Alain Rico, Sr. Manager, Market capital Development, Thermo Fisher Scientific, France
  1. Introduction to Preimplantation Genetic Testing (PGT)
  2. EU IVD Regulation instead of EU MD
  3. Ion Torrent™ ReproSeq™ PGS Reagents (GPR) and Ion Torrent™ GeneStudio™ S5 System (GLE)
  4. Ion Reporter™ Software Aneuploidy Dx Workflows
11:30-14:30 Session 3: Preimplantation genetic testing (PGT)
Moderator: Avner Hershlag, USA
11:30-12:00 The developmental and chromosomal landscape of human embryonic arrest
Christian Ottolini, UK
12:00-12:30 Is PGT always right?
Tony Gordon, UK
12:30-13:00 Cell-free PGTa – better genomic accuracy?
Svetlana Madjunkova, Canada
13:00-13:30 PGT for ‘de novo’ aberrations
Martine De Rycke, Belgium
13:30-14:00 Misconceptions of polygenic risk scoring for embryo selection (PGTP)
Nathan Treff, USA
14:00-14:30 Congress summary and Highlights
Yuval Yaron, Israel